Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PBM will decline by -22.52% over the next 2 Weeks and hit $1.94 by Friday, March 6, 2026. In that time frame, PBM's share price is expected to range between $0.15 and $3.53.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 6, 2026 | 0.11 | 1.83 | 3.64 |
| Mar 5, 2026 | 0.03 | 1.74 | 3.41 |
| Mar 4, 2026 | 0.23 | 2.01 | 3.78 |
| Mar 3, 2026 | 0.18 | 1.89 | 3.66 |
| Mar 2, 2026 | 0.70 | 2.34 | 4.02 |
| Feb 27, 2026 | 0.42 | 2.16 | 3.92 |
| Feb 26, 2026 | 0.23 | 2.07 | 3.76 |
| Feb 25, 2026 | 0.68 | 2.35 | 4.10 |
| Feb 24, 2026 | 0.48 | 2.22 | 3.97 |
| Feb 23, 2026 | 1.01 | 2.68 | 4.38 |
PBM shares fell -4.44% in Friday, February 20, 2026's trading session, dropping from a previous close of $2.62 to move at $2.50. The stock demonstrated notable intraday movement (see PBM's key stats for a full breakdown), fluctuating between $2.47 and $2.64, a +6.88% trading range. While recent weeks have seen some volatility, PBM has managed to secure a -20.13% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 37.94K shares changing hands, 8.53K more than the previous session. This amounted to $94.85K in total market activity.
Will PBM Continue Its Upward Trend?
According to analyst ratings and projections for PBM, Psyence Biomedical Ltd. shares are anticipated to increase by +31.37%, potentially reaching $3.64 per share by March 6, 2026. Short-term technical indicators for PBM currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 21 negative trading days within the past 30 sessions. Based on the PBM stock forecast, now is a good time to buy PBM stock because its current trading price is +36.57% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PBM covering social and institutional perspectives.
PBM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PBM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.49% to 32.25%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 37.56%, hints at potential weakness developing in the medium term. However, the 100-day RSI, at 29.00%, reflects strong bullish momentum over the long term. Insights into PBM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Psyence Biomedical Short-Term Forecasts
PBM Forecast For Next 5 Days
Our algorithm anticipates Psyence Biomedical (PBM) stock could hit $1.91 by Feb 27, 2026. This represents a -23.67% fall from today's price, following a -16.25% change over the past five days.
PBM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Psyence Biomedical Ltd. (PBM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.47, which would mean a -41.20% decrease from the current price of $2.50. Projections for this period range from a high of $3.80 to a low of $0.00.
PBM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Psyence Biomedical's price over the next three months point to a drop. PBM stock is expected to peak at $130.63 on Mar 26, 2026 before potentially dipping to $0.00 on May 22, 2026. On average, PBM is likely to trade around $0.02 in the coming 90 days.
Psyence Biomedical Stock Forecast 2025
Based on our predictive models, Psyence Biomedical (PBM) is expected to trade between $0.00 and $137.51 throughout 2026. This would result in an average price of $0.01, potentially offering investors a -99.60% return from current levels.
Psyence Biomedical Ltd. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Psyence Biomedical Ltd. (PBM) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $109.46, settling at an average of $0.01. This could translate to a -99.60% loss.
March 2026
Based on current market signals, Psyence Biomedical Ltd. is projected to trend march 2026. We forecast a trading range from $0.00 to $130.63, with a likely average price of $0.01. Investors could expect a potential return of -99.60%.
April 2026
Our predictive algorithms indicate Psyence Biomedical Ltd. stock may see a shift in April 2026. The expected range spans $0.00–$116.48, with an average target of $0.02. This represents a cautious outlook and a possible loss of -99.20%.
May 2026
Analyzing established trends, Psyence Biomedical Ltd. looks set to move in May 2026. Projections place the stock between $0.00 and $126.10, averaging around $0.02. This suggests a -99.20% loss from current levels.
June 2026
Market indicators suggest Psyence Biomedical Ltd. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $125.64, with a midpoint forecast of $0.01. The stock might deliver a -99.60% loss.
July 2026
Forecasting for July 2026, models estimate that Psyence Biomedical Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $123.32, averaging $0.01. This signals a cautious trajectory with potential returns around -99.60%.
August 2026
According to our latest forecast models, Psyence Biomedical Ltd. (PBM) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $134.72, settling at an average of $0.01. This could translate to a -99.60% loss.
September 2026
Based on current market signals, Psyence Biomedical Ltd. is projected to trend september 2026. We forecast a trading range from $0.00 to $134.00, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2026
Our predictive algorithms indicate Psyence Biomedical Ltd. stock may see a shift in October 2026. The expected range spans $0.00–$133.46, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2026
Analyzing established trends, Psyence Biomedical Ltd. looks set to move in November 2026. Projections place the stock between $0.00 and $127.30, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Psyence Biomedical Ltd. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $137.51, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Psyence Biomedical Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $127.39, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Psyence Biomedical Ltd. (PBM) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $125.83, settling at an average of $0.00. This could translate to a -100.00% loss.
PBM's history of dividends and stock splits also plays a role in long-term investor confidence.